To study the effect of intratympanic injection with mouse nerve growth factor and methylprednisolone on sudden deafness
-
摘要: 目的:观察鼓室内注射鼠神经生长因子联合甲泼尼松龙治疗突发性聋的疗效。方法:将149例突发性聋患者随机分成2组,对照组常规治疗(扩张血管、改善微循环、营养神经、高压氧)加鼓室内注射甲泼尼龙(0.5 ml)加生理盐水(0.5 ml),每3 d注射1次,连续2周。观察组常规治疗加鼓室内注射甲泼尼龙(0.5 ml)加鼠神经生长因子(0.5 ml),每3 d注射1次,连续2周。结果:观察组听力、耳鸣、眩晕总有效率(93.4%、77.8%、85.2%)均分别优于对照组(80.8%、63.0%、67.2%),差异有统计学意义(P<0.05)。结论:鼓室内注射鼠神经生长因子联合甲泼尼松治疗突发性聋疗效确切,能有效改善患者的听力、耳鸣和眩晕症状。Abstract: Objective: To observe the efficacy of intratympanic injection with mouse nerve growth factor and methylprednisolone on the treatment of sudden deafness.Method: One hundred and forty-nine patients diagnosed as sudden deafness were randomly divided into the control group and the observation group. The control group was treated with the conventional medication and methylprednisolone(0.5 ml)+0.9%NaCl(0.5 ml), once every three days for two weeks. The observation group was added with mouse nerve growth factor(0.5 ml) once every three days for two weeks.Result: The total effective rate in the observation group of hearing, tinnitus and vertigo were respective 93.4%,77.8%,85.2%, which were higher than 80.8%, 63.0%, 67.2%.in the control group.And the differences between them had statistical significance(P<0.05).Conclusion: Effect of the intratympanic injection with mouse nerve growth factor and methylprednisolone on the treatment of sudden deafness is obvious, which can effectively improve hearing level, and relieve tinnitus and vertigo.
-
-
[1] 中华耳鼻咽喉头颈外科杂志编辑委员会, 中华医学会耳鼻咽喉头颈外科学分会. 突发性聋的诊断和治疗指南[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(6):443-447.
[2] 中国突发性聋多中心临床研究协作组. 中国突发性聋分型治疗的多中心临床研究[J]. 中华耳鼻咽喉头颈外科杂志, 2013, 48(5):355-361.
[3] MERCHANT S N, DURAND M L, ADAMS J C. Sudden deafness:Is it viral[J]? J Otorhinolaryngol Head Neck Surg, 2008, 70:52-60.
[4] JADCZAK M, RAPIEJKO P, KANTOR I, et al. Evaluation of hyperbaricoxygen and pharmacological therapy in sudden hearing loss[J].Otolaryngol Pol, 2007, 61:887-891.
[5] GOUVERIS H, SELIVANOVA O, MANN W. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy[J].Eur Arch Otorhinolaryngol, 2005, 262:131-134.
[6] PARNES L S, SUN A H, FREEMAN D J. Corticosteroid pharmacokinetics in the inner ear fluids:an animal study followed by clinical application[J].Laryngoscope,1999,109:1-17.
[7] XENELLIS J,PAPADIMITRIOU N, NIKOLOPOULOS T, et al. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss:a control study[J]. Otolaryngol Head Neck Surg, 2006, 134:940-945.
[8] SALAMA-COHEN P, AREVALO M A, MEIER J,et al. NGF controls dendrite development in hippocampal neurons by binding to p75(NTR) and modulating the cellular targets of notch[J]. Molecular Biol Cell, 2005, 16:339-347.
[9] DAI C F,STEYGER P S,WANG Z M,et al. Expression of TrkA receptors in the mammalian inner ear[J]. Hearing Res,2004,187:1-11.
[10] 王延飞, 赵洪春, 车娟, 等. 鼠神经生长因子联合高压氧治疗突发性聋疗效及预后相关因素分析[J]. 听力学及言语疾病杂志, 2013, 21(6):629-632.
[11] 杨剑, 刘博, 韩德民. 突发性耳聋的循环病因机制[J]. 国际耳鼻咽喉头颈外科杂志, 2006,11(3):175-177.
[12] 李树华, 陶昆耀, 许德珠, 等. 特发性突发性耳聋双侧同时发病与单侧发病者之临床对比研究[J]. 临床耳鼻咽喉科杂志, 1991, 5(3):163-166.
[13] 倪玉苏, 赵霞. 混合氧联合药物治疗突发性耳聋[J]. 临床耳鼻咽喉科杂志, 2004, 18(7):414-415.
[14] ROBERT J, SUJANA S, SANFORD M, et al. Clinical practiceguideline:sudden hearing loss[J]. Otolaryngol Head Neck Surg, 2012, 146:S1-S35.
[15] 杨军, 吴皓. 鼓室内给药治疗内耳疾病的基础与临床[J]. 中华耳鼻咽喉科杂志, 2004, 39(12):770-773.
[16] 陈秀梅, 张庆泉, 解光. 突发性聋的发病时间规律与血液流变学的关系[J]. 中华耳鼻咽喉头颈外科杂志, 2007, 42(3):191-194.
-
计量
- 文章访问数: 69
- PDF下载数: 46
- 施引文献: 0
下载: